Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Nanomaterials (Basel, Switzerland)
|
February 25, 2025
Tattoo Ink Metal Nanoparticles: Assessment of Toxicity In Vitro and with a Novel Human Ex Vivo Model
Beatrice Battistini, Daniela Lulli, Beatrice Bocca, et al.
Biomedicines
|
July 2, 2021
Merkel Cell Carcinoma
Elena Dellambra, Maria Luigia Carbone, Francesca Ricci, et al.
Aging
|
April 18, 2020
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21
Laura Mercurio, Daniela Lulli, Francesca Mascia, et al.
Frontiers in Immunology
|
March 18, 2024
Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors
Martina Morelli, Maria Luigia Carbone, Giovanni Luca Scaglione, et al.
Frontiers in Pharmacology
|
January 22, 2026
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case series
Rosa Falcone, Alessandra Frezzolini, Emanuele Bruni, et al.
Biomedicines
|
December 24, 2021
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
Anna Tosi, Lavinia Nardinocchi, Maria Luigia Carbone, et al.
Scientific Reports
|
April 1, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
Maria Luigia Carbone, Gabriele Madonna, Alessia Capone, et al.
Journal of Cancer Research and Clinical Oncology
|
October 1, 2021
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients
Sofia Verkhovskaia, Francesca Romana Di Pietro, Simona Mastroeni, et al.
Cancers
|
April 14, 2026
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis
Alessia Capone, Maria Luigia Carbone, Simona Mastroeni, et al.
The Journal of Clinical Investigation
|
November 14, 2017
Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis
Maria Luigia Carbone, Gilliane Chadeuf, Sandrine Heurtebise-Chrétien, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Nanomaterials (Basel, Switzerland)
|
February 25, 2025
Tattoo Ink Metal Nanoparticles: Assessment of Toxicity In Vitro and with a Novel Human Ex Vivo Model
Beatrice Battistini, Daniela Lulli, Beatrice Bocca, et al.
Biomedicines
|
July 2, 2021
Merkel Cell Carcinoma
Elena Dellambra, Maria Luigia Carbone, Francesca Ricci, et al.
Aging
|
April 18, 2020
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21
Laura Mercurio, Daniela Lulli, Francesca Mascia, et al.
Frontiers in Immunology
|
March 18, 2024
Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors
Martina Morelli, Maria Luigia Carbone, Giovanni Luca Scaglione, et al.
Frontiers in Pharmacology
|
January 22, 2026
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case series
Rosa Falcone, Alessandra Frezzolini, Emanuele Bruni, et al.
Biomedicines
|
December 24, 2021
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
Anna Tosi, Lavinia Nardinocchi, Maria Luigia Carbone, et al.
Scientific Reports
|
April 1, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
Maria Luigia Carbone, Gabriele Madonna, Alessia Capone, et al.
Journal of Cancer Research and Clinical Oncology
|
October 1, 2021
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients
Sofia Verkhovskaia, Francesca Romana Di Pietro, Simona Mastroeni, et al.
Cancers
|
April 14, 2026
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis
Alessia Capone, Maria Luigia Carbone, Simona Mastroeni, et al.
The Journal of Clinical Investigation
|
November 14, 2017
Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis
Maria Luigia Carbone, Gilliane Chadeuf, Sandrine Heurtebise-Chrétien, et al.
Page
of 3